Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 51

1.

Interpretation of Erythropoietin and Haemoglobin Levels in Patients with Various Stages of Chronic Kidney Disease.

Panjeta M, Tahirović I, Sofić E, Ćorić J, Dervišević A.

J Med Biochem. 2017 Apr 22;36(2):145-152. doi: 10.1515/jomb-2017-0014. eCollection 2017 Apr.

2.

The Ferumoxytol for Anemia of CKD Trial (FACT)-a randomized controlled trial of repeated doses of ferumoxytol or iron sucrose in patients on hemodialysis: background and rationale.

Macdougall IC, Dahl NV, Bernard K, Li Z, Batyky A, Strauss WE.

BMC Nephrol. 2017 Apr 3;18(1):117. doi: 10.1186/s12882-017-0523-8.

3.

Renal functional outcomes after surgery for renal cortical tumors.

Lascano D, Finkelstein JB, DeCastro GJ, McKiernan JM.

J Kidney Cancer VHL. 2015 Apr 4;2(2):45-54. doi: 10.15586/jkcvhl.2015.26. eCollection 2015.

4.

Increased serum hepcidin contributes to the anemia of chronic kidney disease in a murine model.

Hanudel MR, Rappaport M, Gabayan V, Jung G, Salusky IB, Nemeth E, Ganz T, Zaritsky J.

Haematologica. 2017 Mar;102(3):e85-e88. doi: 10.3324/haematol.2016.150433. Epub 2016 Nov 24. No abstract available.

5.

Effects of dietary iron intake and chronic kidney disease on fibroblast growth factor 23 metabolism in wild-type and hepcidin knockout mice.

Hanudel MR, Chua K, Rappaport M, Gabayan V, Valore E, Goltzman D, Ganz T, Nemeth E, Salusky IB.

Am J Physiol Renal Physiol. 2016 Dec 1;311(6):F1369-F1377. doi: 10.1152/ajprenal.00281.2016. Epub 2016 Oct 12.

PMID:
27733366
6.

Diabetes mellitus increases the prevalence of anemia in patients with chronic kidney disease: A nested case-control study.

Loutradis C, Skodra A, Georgianos P, Tolika P, Alexandrou D, Avdelidou A, Sarafidis PA.

World J Nephrol. 2016 Jul 6;5(4):358-66. doi: 10.5527/wjn.v5.i4.358.

7.

Impact of low hemoglobin on the development of contrast-induced nephropathy: A retrospective cohort study.

Xu J, Zhang M, Ni Y, Shi J, Gao R, Wang F, Dong Z, Zhu L, Liu Y, Xu H.

Exp Ther Med. 2016 Aug;12(2):603-610. Epub 2016 Jun 2.

8.

High-dose vitamin D3 reduces circulating hepcidin concentrations: A pilot, randomized, double-blind, placebo-controlled trial in healthy adults.

Smith EM, Alvarez JA, Kearns MD, Hao L, Sloan JH, Konrad RJ, Ziegler TR, Zughaier SM, Tangpricha V.

Clin Nutr. 2017 Aug;36(4):980-985. doi: 10.1016/j.clnu.2016.06.015. Epub 2016 Jun 27.

PMID:
27402475
9.
10.

Anemia and risk for cognitive decline in chronic kidney disease.

Kurella Tamura M, Vittinghoff E, Yang J, Go AS, Seliger SL, Kusek JW, Lash J, Cohen DL, Simon J, Batuman V, Ordonez J, Makos G, Yaffe K.

BMC Nephrol. 2016 Jan 28;17:13. doi: 10.1186/s12882-016-0226-6.

11.

Erythropoiesis-stimulating Agents and Anemia in Patients with Non-dialytic Chronic Kidney Disease.

Kim SM, Kim KM, Kwon SK, Kim HY.

J Korean Med Sci. 2016 Jan;31(1):55-60. doi: 10.3346/jkms.2016.31.1.55. Epub 2015 Dec 24.

12.

Impacts of anemia on 3-year ischemic events in patients undergoing percutaneous coronary intervention: a propensity-matched study.

Wang X, Qiu M, Li J, Wang H, Qi J, Wang G, Xu K, Liu H, Zhao X, Jing Q, Li Y, Han Y.

J Thorac Dis. 2015 Nov;7(11):1951-9. doi: 10.3978/j.issn.2072-1439.2015.10.66.

13.

Impact of anaemia on lung function and exercise capacity in patients with stable severe chronic obstructive pulmonary disease.

Guo J, Zheng C, Xiao Q, Gong S, Zhao Q, Wang L, He J, Yang W, Shi X, Sun X, Liu J.

BMJ Open. 2015 Oct 8;5(10):e008295. doi: 10.1136/bmjopen-2015-008295.

14.

Predictors of anemia in a multi-ethnic chronic kidney disease population: a case-control study.

Lau BC, Ong KY, Yap CW, Vathsala A, How P.

Springerplus. 2015 May 20;4:233. doi: 10.1186/s40064-015-1001-z. eCollection 2015.

15.

Cardiovascular events and all-cause mortality in a cohort of 57,946 patients with type 2 diabetes: associations with renal function and cardiovascular risk factors.

Cea Soriano L, Johansson S, Stefansson B, Rodríguez LA.

Cardiovasc Diabetol. 2015 Apr 18;14:38. doi: 10.1186/s12933-015-0204-5.

16.

Parathyroid hormone may be an early predictor of low serum hemoglobin concentration in patients with not advanced stages of chronic kidney disease.

Russo D, Morrone L, Di Iorio B, Andreucci M, De Gregorio MG, Errichiello C, Russo L, Locatelli F.

J Nephrol. 2015 Dec;28(6):701-8. doi: 10.1007/s40620-014-0129-1. Epub 2014 Aug 12.

17.

Anemia is independently associated with NT-proBNP levels in asymptomatic predialysis patients with chronic kidney disease.

Tirmenstajn-Jankovic B, Dimkovic N, Perunicic-Pekovic G, Radojicic Z, Bastac D, Zikic S, Zivanovic M.

Hippokratia. 2013 Oct;17(4):307-12.

18.

Trends in anemia care in older patients approaching end-stage renal disease in the United States (1995-2010).

Winkelmayer WC, Mitani AA, Goldstein BA, Brookhart MA, Chertow GM.

JAMA Intern Med. 2014 May;174(5):699-707.

19.

A 3-marker index improves the identification of iron disorders in CKD anaemia.

Mercadal L, Metzger M, Haymann JP, Thervet E, Boffa JJ, Flamant M, Vrtovsnik F, Gauci C, Froissart M, Stengel B; NephroTest Study Group.

PLoS One. 2014 Feb 19;9(2):e84144. doi: 10.1371/journal.pone.0084144. eCollection 2014. Erratum in: PLoS One. 2014;9(6):e100606.

20.

Prevalence of anemia in chronic kidney disease in the United States.

Stauffer ME, Fan T.

PLoS One. 2014 Jan 2;9(1):e84943. doi: 10.1371/journal.pone.0084943. eCollection 2014.

Supplemental Content

Support Center